U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460518) titled 'Tranexamic Acid for Bleeding Reduction During TURP Surgery' on March 01.
Brief Summary: Transurethral resection of the prostate (TURP) is commonly performed in elderly patients and may be associated with perioperative bleeding leading to postoperative anemia and delayed recovery. Tranexamic acid (TXA), an antifibrinolytic agent, may reduce surgical bleeding by inhibiting fibrin degradation.
This prospective randomized quadruple-blind placebo-controlled clinical trial evaluates whether perioperative administration of intravenous tranexamic acid reduces intraoperative blood loss and preserves postoperative hemoglobin concentration i...